Home › Companies › Esperion Therapeutics, Inc.
How asset managers voted at Esperion Therapeutics, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | Esperion Therapeutics, Inc. | 9 | 164 |
| 2024-2025 | Esperion Therapeutics, Inc. | 6 | 144 |
| 2023-2024 | ESPERION THERAPEUTICS INC. | 7 | 110 |
Earlier seasons list this company under the name ESPERION THERAPEUTICS INC., as its holders filed it.
Explore Esperion Therapeutics, Inc. in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built October 13, 2026.